Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Feb 22, 2005
(February 22, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in its ATLAS clinical trial. ATLAS is the first trial using Boston Scientific's...
-
Feb 16, 2005
(February 16, 2005) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the Interventional Procedures Advisory Committee (IPAC) of the United Kingdom's National...
-
Feb 2, 2005
(February 2, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2005 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference, which is...
-
Feb 1, 2005
and New York, NY (February 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) today provided financial guidance for 2005 and announced financial goals for 2006 and 2007 at a meeting with...
-
Jan 31, 2005
(January 31, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has completed the initial launch of its TAXUS® Liberté™ paclitaxel-eluting coronary stent system. On...
-
Jan 27, 2005
(January 27, 2005) -- Boston Scientific Corporation (NYSE: BSX) will simultaneously webcast the analyst meeting it is hosting on Tuesday, February 1. The meeting is scheduled to begin at 9:00 a.m....
-
Jan 20, 2005
(January 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2005 Piper Jaffray Health Care Conference, which is being held January 25-27 in New York City....
-
Jan 19, 2005
(January 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the implantation of its millionth TAXUS® Express2™ paclitaxel-eluting coronary stent system, marking a major...
-
Jan 17, 2005
(January 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has launched its TAXUS™ Liberté™ paclitaxel-eluting coronary stent system in 18 countries. The TAXUS...
-
Jan 10, 2005
and San Francisco, CA (January 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced preliminary, unaudited sales results for the fourth quarter and for the year ended December...